Literature DB >> 27604324

A Partial E3 Deletion in Replication-Defective Adenoviral Vectors Allows for Stable Expression of Potentially Toxic Transgene Products.

Larissa H Haut1, Amanda L Gill1,2, Raj K Kurupati1, Ang Bian1, Yan Li1, Wynetta Giles-Davis1, Zhiquan Xiang1, Xiang Yang Zhou1, Hildegund C J Ertl1.   

Abstract

Adenovirus (Ad) is used extensively for construction of viral vectors, most commonly with deletion in its E1 and/or E3 genomic regions. Previously, our attempts to insert envelope proteins (Env) of HIV-1 into such vectors based on chimpanzee-derived Ad (AdC) viruses were thwarted. Here, we describe that genetic instability of an E1- and E3-deleted AdC vector of serotype C6 expressing Env of HIV-1 can be overcome by reinsertion of E3 sequences with anti-apoptotic activities. This partial E3 deletion presumably delays premature death of HEK-293 packaging cell lines due to Env-induced cell apoptosis. The same partial E3 deletion also allows for the generation of stable glycoprotein 140 (gp140)- and gp160-expressing Ad vectors based on AdC7, a distinct AdC serotype. Env-expressing AdC vectors containing the partial E3 deletion are genetically stable upon serial cell culture passaging, produce yields comparable to those of other AdC vectors, and induce transgene product-specific antibody responses in mice. A partial E3 deletion thereby allows expansion of the repertoire of transgenes that can be expressed by Ad vectors.

Entities:  

Keywords:  HIV-1; genetic stability; immune responses; vaccine

Mesh:

Substances:

Year:  2016        PMID: 27604324      PMCID: PMC5069709          DOI: 10.1089/hgtb.2016.044

Source DB:  PubMed          Journal:  Hum Gene Ther Methods        ISSN: 1946-6536            Impact factor:   2.396


  44 in total

Review 1.  Progress on adenovirus-vectored universal influenza vaccines.

Authors:  Kui Xiang; Guan Ying; Zhou Yan; Yan Shanshan; Zhang Lei; Li Hongjun; Sun Maosheng
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  The innate immune response to adenovirus vectors.

Authors:  Daniel A Muruve
Journal:  Hum Gene Ther       Date:  2004-12       Impact factor: 5.695

Review 3.  Adenoviruses as gene/vaccine delivery vectors: promises and pitfalls.

Authors:  Mohan Babu Appaiahgari; Sudhanshu Vrati
Journal:  Expert Opin Biol Ther       Date:  2014-12-22       Impact factor: 4.388

4.  Protection of non-human primates against rabies with an adenovirus recombinant vaccine.

Authors:  Z Q Xiang; L Greenberg; H C Ertl; C E Rupprecht
Journal:  Virology       Date:  2014-01-09       Impact factor: 3.616

5.  Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection.

Authors:  Kevin O Saunders; Amarendra Pegu; Ivelin S Georgiev; Ming Zeng; M Gordon Joyce; Zhi-Yong Yang; Sung-Youl Ko; Xuejun Chen; Stephen D Schmidt; Ashley T Haase; John-Paul Todd; Saran Bao; Peter D Kwong; Srinivas S Rao; John R Mascola; Gary J Nabel
Journal:  J Virol       Date:  2015-03-18       Impact factor: 5.103

6.  Vaccination with an adenoviral vector expressing calreticulin-human papillomavirus 16 E7 fusion protein eradicates E7 expressing established tumors in mice.

Authors:  Jorge G Gomez-Gutierrez; Kutlu G Elpek; Roberto Montes de Oca-Luna; Haval Shirwan; H Sam Zhou; Kelly M McMasters
Journal:  Cancer Immunol Immunother       Date:  2006-12-05       Impact factor: 6.968

7.  Three adenovirus E3 proteins cooperate to evade apoptosis by tumor necrosis factor-related apoptosis-inducing ligand receptor-1 and -2.

Authors:  C A Benedict; P S Norris; T I Prigozy; J L Bodmer; J A Mahr; C T Garnett; F Martinon; J Tschopp; L R Gooding; C F Ware
Journal:  J Biol Chem       Date:  2000-10-24       Impact factor: 5.157

8.  Adenovirus-based vaccines against rhesus lymphocryptovirus EBNA-1 induce expansion of specific CD8+ and CD4+ T cells in persistently infected rhesus macaques.

Authors:  R Leskowitz; M H Fogg; X Y Zhou; A Kaur; E L V Silveira; F Villinger; P M Lieberman; F Wang; H C Ertl
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 9.  Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses.

Authors:  H G Burgert; J H Blusch
Journal:  Virus Genes       Date:  2000       Impact factor: 2.198

10.  Immunogenicity without Efficacy of an Adenoviral Tuberculosis Vaccine in a Stringent Mouse Model for Immunotherapy during Treatment.

Authors:  S Anisah Alyahya; Scott T Nolan; Cara M R Smith; William R Bishai; Jerald Sadoff; Gyanu Lamichhane
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

View more
  1 in total

1.  Porcine Adenovirus Type 3 E3 Encodes a Structural Protein Essential for Capsid Stability and Production of Infectious Progeny Virions.

Authors:  Abdelrahman Said; Tekeleselassie A Woldemariam; Suresh K Tikoo
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.